The Group has continued to make solid progress in challenging markets
· Improved performance in the second half by both AEP and ECS as management actions have taken effect
· Oil & gas businesses increased shares in difficult markets; AEP medical businesses achieved an improved result
· ECS North America refocusing/restructuring delivering to plan; further progress in Australia
· Operating cash flow of £62.2m, leading to year end net debt of £150.0m (similar to last year, before currency effects)
· Further significant cost savings of £42m achieved
· Final dividend of 2.0p, making 3.0p for the year
· Current year anticipated to be modestly ahead of previous expectations in addition to currency benefit.
